Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Triplette

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Chest|June 24, 2025
Components Necessary for High-Quality Lung Cancer Screening: A 10-Year UpdateJulie A Barta, Douglas Arenberg, Leah Backhus, et al.
Research Square|December 3, 2025
"It's coming whether we want it to or not": A qualitative exploration of older adults' comfort with and perceptions of technology and digital healthAnjali Vasavada, Lorella Palazzo, Casey Luce, et al.
Chest|September 12, 2025
Effectiveness of Health Communication Intervention to Improve Knowledge on Timeliness to Return for Annual Lung Cancer Screening: The Larch TrialKaren J Wernli, Melissa L Anderson, Lorella Palazzo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2020
Endothelial Activation, Innate Immune Activation, and Inflammation Are Associated With Postbronchodilator Airflow Limitation and Obstruction Among Adolescents Living With HIVEngi F Attia, Pavan K Bhatraju, Matthew Triplette, et al.
American Journal of Respiratory and Critical Care Medicine|October 1, 2020
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society StatementM Patricia Rivera, Hormuzd A Katki, Nichole T Tanner, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2025
Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research StatementLouise M Henderson, Roger Y Kim, Nichole T Tanner, et al.
Annals of Internal Medicine|June 29, 2026
Performance of Lung Cancer Risk Prediction Models in Different Racial and Ethnic Groups in the United States: Results From the Lung Cancer Cohort ConsortiumXiaoshuang Feng, Florence Guida, Aghiles Guenoun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyPeter G Shields, Laura Bierut, Douglas Arenberg, et al.
JAMA|May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk ModelHana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Environmental Health Perspectives|May 21, 2025
Circulating per- and polyfluoroalkyl substances and liver cancer risk: a nested case-control analysis of individual participant data from 12 prospective cohortsCody Z Watling, Jessica L Petrick, Barry I Graubard, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Chest|June 24, 2025
Components Necessary for High-Quality Lung Cancer Screening: A 10-Year UpdateJulie A Barta, Douglas Arenberg, Leah Backhus, et al.
Research Square|December 3, 2025
"It's coming whether we want it to or not": A qualitative exploration of older adults' comfort with and perceptions of technology and digital healthAnjali Vasavada, Lorella Palazzo, Casey Luce, et al.
Chest|September 12, 2025
Effectiveness of Health Communication Intervention to Improve Knowledge on Timeliness to Return for Annual Lung Cancer Screening: The Larch TrialKaren J Wernli, Melissa L Anderson, Lorella Palazzo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2020
Endothelial Activation, Innate Immune Activation, and Inflammation Are Associated With Postbronchodilator Airflow Limitation and Obstruction Among Adolescents Living With HIVEngi F Attia, Pavan K Bhatraju, Matthew Triplette, et al.
American Journal of Respiratory and Critical Care Medicine|October 1, 2020
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society StatementM Patricia Rivera, Hormuzd A Katki, Nichole T Tanner, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2025
Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research StatementLouise M Henderson, Roger Y Kim, Nichole T Tanner, et al.
Annals of Internal Medicine|June 29, 2026
Performance of Lung Cancer Risk Prediction Models in Different Racial and Ethnic Groups in the United States: Results From the Lung Cancer Cohort ConsortiumXiaoshuang Feng, Florence Guida, Aghiles Guenoun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyPeter G Shields, Laura Bierut, Douglas Arenberg, et al.
JAMA|May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk ModelHana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Environmental Health Perspectives|May 21, 2025
Circulating per- and polyfluoroalkyl substances and liver cancer risk: a nested case-control analysis of individual participant data from 12 prospective cohortsCody Z Watling, Jessica L Petrick, Barry I Graubard, et al.
Pageof 7